TMC Venture Fund

We are thrilled to announce the closing of our $15M Series A-2 financing. A portion of the proceeds will support our 304-patient “MAFASA” clinical trial for EchoMark & EchoSure.    The funding comes on the heels of recent milestones including strong clinical data, a new CPT code, FDA IDE approval for the MAFASA pivotal trial, and grant funding to support the advancement of EchoGuide.    Read more about it here: https://lnkd.in/ePrttCMZ

We’re pleased to share that we’ve secured $28.4 million in an oversubscribed Series A financing round, co-led by Mission BioCapital and 4BIO Capital. This milestone brings our total funding to over $51 million and will help us accelerate the Phase 2 development of MB-105, our lead CAR-T therapy candidate for T-cell lymphoma – a type of cancer with a poor prognosis and limited treatment options.   Launching our Series A with a Phase 2 ready asset is something we're proud of and we are determined to push forward to provide new hope for patients with cancer who have few treatment options. We’re grateful to our new and existing investors for their confidence in our mission to transform the treatment landscape for challenging cancers!   https://lnkd.in/gySMtkWc #CellTherapy #Oncology #CancerResearch #SeriesA #CART #BiotechInnovation KdT Ventures TMC Venture Fund Portal Innovations, LLC Cancer Focus Fund Small Ventures USA LLC Alexandria Real Estate Equities, Inc. Modi Ventures Joe Mansueto Nancy Chang Stefan Wildt Cassidy Blundell Owen Smith Cancer Prevention and Research Institute of Texas

Prana Thoracic is thrilled to announce the successful closing of our Series A extension round, raising an additional $3 million in an oversubscribed funding round, bringing our total funding to $9 million! This milestone highlights the strong investor confidence in Prana Thoracic’s innovative approach to transforming lung cancer treatment. The additional capital will accelerate our product development and support our clinical and regulatory advancements, bringing us closer to offering precision surgical solutions to patients worldwide. Read the full press release: https://lnkd.in/gJXfPTnS #PranaThoracic #SurgicalSolutions #Innovation #Medtech #HealthcareInnovation

Koda Health Secures New Funding and Strategic Partners to Expand ACP Capabilities! We are thrilled to announce the successful oversubscription of our Seed+ funding round, led by Ecliptic Capital, with strategic #investments from Memorial Hermann Health System, AARP, and the Texas Medical Center Venture Fund. This significant funding milestone supports Koda Health’s mission to transform Advance Care Planning, ensuring each individual’s end-of-life wishes are honored with respect and diligence. "If we’re looking at speed of market adoption, it’s clear that Koda Health is at the forefront of a crucial transformation in Advance Care Planning. In just a few years, we’ve built out a product that now serves well over 700,000 patients nationwide for industry giants like Cigna, Privia and Houston Methodist,” reflected Koda’s CEO Tatiana Fofanova, Ph.D., who diligently guided Koda through this raise. Desh Mohan, MD Mohan, our Chief Medical Officer, emphasized the clinical implications of strategically aligning with key players in health care to bolster our growth: "It was crucial for the company to fill its latest #fundinground with strategic investors." This influx of support and capital will not only help us innovate but also expand our services and further strengthen our commitments to patients and healthcare providers. Currently, over 700,000 individuals benefit from our solutions, backed by endorsements from industry leaders. Our future plans include expanding partnerships and enhancing our technological framework, propelling us to set new standards in patient care and #AdvanceCarePlanning. ➡️ Swipe through the carousel to see what key leaders from Ecliptic Capital, Memorial Hermann Health System, AARP, and TMC Venture Fund are saying about their investment in Koda Health! 🖇️To learn more about this transformative initiative and hear directly from our new investors visit the link: https://lnkd.in/egnStGCn